Tata Chemicals falls sharply around ₹693–719, making it the biggest loser among Tata Group stocks. The decline comes amid boardroom turmoil at Tata Sons over N. Chandrasekaran’s reappointment and uncertainty around a potential Tata Sons listing.
📉 Stock Market Impact (18 Sept 2026)
Tata Chemicals: Down 7.7–11.5%, trading around ₹693–719
Other Tata Group stocks:
TCS: ↓ 3–4%
Tata Motors Passenger Vehicles: ↓ 2.5–3.5%
Tata Power: ↓ 1–2%
Tata Investment Corporation: ↓ 2.5–3.9%
Tata Steel: marginal decline
Tata Capital: bucked trend, ↑ 1–2%
⚠️ Reasons for the Fall
Boardroom Crisis: Tata Trusts opposed the Tata Sons board’s decision to reappoint N. Chandrasekaran as Executive Chairman for another 5 years, calling the resolution a “legal nullity.”
Regulatory Pressure: RBI has directed Tata Sons to comply with listing requirements as an Upper Layer NBFC, reviving the prospect of a public listing.
SP Group Proposal: Shapoorji Pallonji Group proposed monetising part of its Tata Sons stake (~₹25,000 crore), raising questions about ownership structure and liquidity.
Tata Trusts’ Position: Reiterated opposition to Tata Sons going public, insisting on preserving the century‑old private structure.
📊 Tata Chemicals Q2 FY26 Results (Released Today)
Revenue: ₹3,877 crore (↑ 4.25% QoQ)
Operating Profit: ₹187 crore (↓ 49.3% QoQ)
PAT: ₹77 crore (↓ 69.4% QoQ)
Operating Margin: 4.82%
EPS: ₹4.68 (↓ 52.6% QoQ)
🔍 Market Sentiment
Bearish Trend: Technical indicators show strong downtrend in Tata Chemicals.
Investor Concerns: Leadership uncertainty at Tata Sons, regulatory listing pressure, and weak quarterly earnings have combined to trigger heavy selling.
Short‑Term Outlook: Volatile until clarity emerges on Tata Sons’ governance and listing path.